Free Trial

Bellevue Healthcare (BBH) Competitors

Bellevue Healthcare logo
GBX 115.60 -2.60 (-2.20%)
As of 04/17/2025 12:29 PM Eastern

BBH vs. N91, TFG, LWDB, VEIL, FCSS, GSS, ASL, JMG, EDIN, and JPE

Should you be buying Bellevue Healthcare stock or one of its competitors? The main competitors of Bellevue Healthcare include Ninety One Group (N91), Tetragon Financial (TFG), Law Debenture (LWDB), Vietnam Enterprise (VEIL), Fidelity China Special (FCSS), Genesis Emerging Markets Fund (GSS), Aberforth Smaller Companies Trust (ASL), JPMorgan Emerging Markets (JMG), Edinburgh Investment (EDIN), and JPMorgan Elect plc ­- Managed Growth (JPE). These companies are all part of the "asset management" industry.

Bellevue Healthcare vs.

Bellevue Healthcare (LON:BBH) and Ninety One Group (LON:N91) are both small-cap financial services companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability, community ranking and analyst recommendations.

Bellevue Healthcare pays an annual dividend of GBX 6 per share and has a dividend yield of 5.2%. Ninety One Group pays an annual dividend of GBX 12 per share and has a dividend yield of 8.7%. Bellevue Healthcare pays out -91.3% of its earnings in the form of a dividend. Ninety One Group pays out 69.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Ninety One Group has higher revenue and earnings than Bellevue Healthcare. Bellevue Healthcare is trading at a lower price-to-earnings ratio than Ninety One Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bellevue Healthcare-£9.60M-29.69-£16.23M-£6.57-17.58
Ninety One Group£586.81M2.07£154.01M£17.377.92

Ninety One Group has a consensus target price of GBX 173, suggesting a potential upside of 25.82%. Given Ninety One Group's stronger consensus rating and higher possible upside, analysts clearly believe Ninety One Group is more favorable than Bellevue Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bellevue Healthcare
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Ninety One Group
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Bellevue Healthcare's average media sentiment score of 0.00 equaled Ninety One Group'saverage media sentiment score.

Company Overall Sentiment
Bellevue Healthcare Neutral
Ninety One Group Neutral

Bellevue Healthcare received 109 more outperform votes than Ninety One Group when rated by MarketBeat users. Likewise, 68.52% of users gave Bellevue Healthcare an outperform vote while only 13.33% of users gave Ninety One Group an outperform vote.

CompanyUnderperformOutperform
Bellevue HealthcareOutperform Votes
111
68.52%
Underperform Votes
51
31.48%
Ninety One GroupOutperform Votes
2
13.33%
Underperform Votes
13
86.67%

Bellevue Healthcare has a net margin of 169.10% compared to Ninety One Group's net margin of 26.24%. Ninety One Group's return on equity of 42.90% beat Bellevue Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Bellevue Healthcare169.10% -4.48% N/A
Ninety One Group 26.24%42.90%1.15%

40.6% of Bellevue Healthcare shares are held by institutional investors. Comparatively, 26.8% of Ninety One Group shares are held by institutional investors. 0.1% of Bellevue Healthcare shares are held by company insiders. Comparatively, 58.3% of Ninety One Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Ninety One Group beats Bellevue Healthcare on 11 of the 16 factors compared between the two stocks.

Get Bellevue Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BBH vs. The Competition

MetricBellevue HealthcareAsset Management IndustryFinancial SectorLON Exchange
Market Cap£284.91M£1.09B£3.66B£2.48B
Dividend Yield3.82%4.43%4.20%4.96%
P/E Ratio-17.5823.6314.01129.75
Price / Sales-29.692,224.361,657.54232,042.22
Price / CashN/A60.9450.1928.07
Price / Book0.771.103.334.43
Net Income-£16.23M£260.34M£1.23B£5.83B
7 Day Performance1.58%2.64%2.01%3.01%
1 Month Performance-7.81%1.67%0.62%-1.06%
1 Year Performance-18.59%1.56%9.70%102.51%

Bellevue Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BBH
Bellevue Healthcare
N/AGBX 115.60
-2.2%
N/A-18.6%£284.91M£-9,595,061.74-17.58N/AGap Up
N91
Ninety One Group
N/AGBX 125.60
+4.6%
GBX 173
+37.7%
-17.7%£1.11B£586.81M7.231,180Gap Up
TFG
Tetragon Financial
N/AGBX 13.67
+1.3%
N/A+41.0%£1.11B£22.12B8.77N/A
LWDB
Law Debenture
N/AGBX 820
+4.1%
N/A+7.7%£1.08B£203.87M7.63260News Coverage
High Trading Volume
VEIL
Vietnam Enterprise
N/AGBX 471
-1.6%
N/A-10.2%£1.08B£17.87M-318.13N/ANews Coverage
FCSS
Fidelity China Special
N/AGBX 216.50
+0.9%
N/A+11.5%£1.07B£-177,570,734.591.07N/AGap Down
GSS
Genesis Emerging Markets Fund
N/AN/AN/AN/A£1.06B£250.40M6.181,626Gap Down
ASL
Aberforth Smaller Companies Trust
N/AGBX 1,254.06
+3.5%
N/A-2.9%£1.05B£226.05M4.12N/ANews Coverage
Positive News
High Trading Volume
JMG
JPMorgan Emerging Markets
N/AGBX 97.10
+1.9%
N/A-1.9%£1.03B£97.45M12.86N/AInsider Trade
News Coverage
Gap Down
High Trading Volume
EDIN
Edinburgh Investment
N/AGBX 698
+2.6%
N/A+7.5%£1.01B£189.32M5.58N/A
JPE
JPMorgan Elect plc ­- Managed Growth
N/AN/AN/AN/A£1.00B£104.78M1,250.00N/A

Related Companies and Tools


This page (LON:BBH) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners